by Nina DiPrimio | Oct 17, 2018 | GSD III |
I’m happy to announce that the Perlara family has grown! We recently launched a new PerlQuest for glycogen storage disease type III (GSDIII) – also known as Cori disease – in collaboration with Richard Taylor of the Warren Center and the University of...
by Nina DiPrimio | Oct 11, 2018 | Sanfilippo syndrome |
Hello readers! I’m eager to share some news with you: Perlara has signed new PerlQuests! One of our latest drug discovery efforts is a mucopolysaccharadosis (lysosomal storage diseases MPSIIIA and MPSIIIB) collaboration with Cure Sanfilippo Foundation...
by Nina DiPrimio | Mar 26, 2018 | UDN |
This is my first post in a few months, and a lot has changed at Perlara since then! We doubled in size, expanding and creating more research teams, and launched multiple new PerlQuests. Our latest news is that we have launched a collaboration with the Undiagnosed...
by Nina DiPrimio | Jan 12, 2017 | Perlara science |
Well it has been a little while since I wrote a post, and a lot has happened since then, which I am sure you read about in our blogs and tweets. We changed our company name, partnered with Novartis and started partnering with patient groups to engineer our organisms...
by Nina DiPrimio | Jul 5, 2016 | Uncategorized |
I have been anxiously awaiting this moment, the time in which I can write a blog post on our pilot study with Vium, formerly Mousera. Perlstein Lab had an opportunity to work with Vium starting about one year prior to their out-of-stealth launch, and I am itching to...
